Parnax Lab Profit & Loss Annual

BSE: 506128 | NSE: - | ISIN: INE383L01019 | Sector: Biotechnology & Drugs
103.00 -0.50 (-0.48%)Updated : 30 Jun 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Revenue 187.74188.71167.61163.03
Total Revenue 187.74188.71167.61163.03
Costof Revenue Total 96.00102.8189.6489.64
Gross Profit 91.7485.9077.9673.39
Selling/ General/ Admin Expenses Total 24.4323.7254.7217.43
Depreciation/ Amortization 7.386.966.535.87
Other Operating Expenses Total 40.5438.610.1832.93
Total Operating Expense 168.35172.11151.13145.87
Operating Income 19.3916.6016.4817.16
Interest Inc( Exp) Net- Non- Op Total -5.39-5.00-4.24-4.79
Other Net 1.680.420.03-0.11
Net Income Before Taxes 15.6712.0512.2812.26
Provisionfor Income Taxes 4.132.423.654.01
Net Income After Taxes 11.549.628.638.26
Minority Interest -0.02-0.02-0.01-0.02
Net Income Before Extra Items 11.529.618.628.24
Net Income 11.529.618.628.24
Total Adjustmentsto Net Income 0.00---
Income Availableto Com Excl Extra Ord 11.529.618.628.24
Income Availableto Com Incl Extra Ord 11.529.618.628.24
Diluted Net Income 11.529.618.628.24
Diluted Weighted Average Shares 1.151.151.110.85
Diluted EPS Excluding Extra Ord Items 10.058.377.799.68
Diluted Normalized EPS 10.058.347.829.68
period Length 12.0012.0012.0012.00
period Type ----
Gain( Loss)on Saleof Assets -0.030.010.00
Unusual Expense( Income) --0.06-
*All figures in crores except per share values
Recommended For You
Trending Stocks
871.80+14.05(1.64%)
2,054.35+11.45(0.56%)
1,199.40-25.80 (-2.11%)
2,163.10-44.90 (-2.03%)